electroCore (ECOR) Cash from Operations Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.69% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -84.38% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.43% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 185.96% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 16.00% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.60% |
| 10 | electroCore | 92,394.96 | -8.79 Mn | 8.36 Mn | 30.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.93% |
| Dec 31, 2025 | 17.90% |
| Sep 30, 2025 | 83.30% |
| Jun 30, 2025 | -136.65% |
| Mar 31, 2025 | -267.50% |
| Dec 31, 2024 | 293.53% |
| Sep 30, 2024 | -534.48% |
| Jun 30, 2024 | -88.71% |
| Mar 31, 2024 | 144.37% |
| Dec 31, 2023 | 179.72% |
| Sep 30, 2023 | 149.92% |
| Jun 30, 2023 | 564.24% |
| Mar 31, 2023 | -22.59% |
| Dec 31, 2022 | 7.81% |
| Sep 30, 2022 | -33.65% |
| Jun 30, 2022 | 67.64% |
| Mar 31, 2022 | -213.81% |
| Dec 31, 2021 | -111.91% |
| Sep 30, 2021 | 12.93% |
| Jun 30, 2021 | -149.36% |
| Mar 31, 2021 | 149.47% |
| Dec 31, 2020 | 501.29% |
| Sep 30, 2020 | 51.94% |
| Jun 30, 2020 | 64.47% |
| Mar 31, 2020 | 48.23% |
| Dec 31, 2019 | 25.17% |
| Sep 30, 2019 | 41.01% |
| Jun 30, 2019 | -0.22% |
| Mar 31, 2019 | -69.47% |
| Dec 31, 2018 | -51.75% |
| Sep 30, 2018 | -112.09% |